Literature DB >> 12167433

Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.

Y Imai1, T Sasaki, Y Shinagawa, K Akimoto, T Fujibayashi.   

Abstract

In this study, we investigated the expression of the KAI1/CD82 gene in oral squamous cell carcinoma (oral SCC). We studied 43 oral SCC patients. Reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed to evaluate expression of this gene, and results were compared to the clinico-pathological findings. Twenty-five specimens (58.1%) were KAI1/CD82-positive, and 18 (41.9%) were negative. There were statistically significant relationships between gene expression and both histological malignancy (P=0.0205) and mode of invasion (P=0.0315). But there were no correlations of expression with tumor status, regional lymph node metastasis, pathological lymph node metastasis or histological differentiation. No significant relationship was observed between patient survival and expression of KAI1/CD82 by tumors. The results of this study suggest that the KAI1/CD82 gene may not be a useful predictor of prognosis, although decreased gene expression may be associated with increased invasive ability of oral SCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167433     DOI: 10.1016/s1368-8375(01)00120-8

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  7 in total

1.  Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells.

Authors:  Sui-Hai Si; Jian-Min Yang; Zhi-Hong Peng; Yuan-Hui Luo; Ping Zhou
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

Review 2.  Cancer stem cells as targets for cancer therapy: selected cancers as examples.

Authors:  Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

3.  Effects of KAI1/CD82 on biological behavior of human colorectal carcinoma cell line.

Authors:  Li Liu; De-Hua Wu; Zu-Guo Li; Guang-Zhi Yang; Yan-Qing Ding
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

4.  Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia.

Authors:  P Nankivell; H Williams; C McConkey; K Webster; A High; K MacLennan; B Senguven; P Rabbitts; H Mehanna
Journal:  Br J Cancer       Date:  2013-11-07       Impact factor: 7.640

5.  KAI-1 and p53 expression in oral squamous cell carcinomas: Markers of significance in future diagnostics and possibly therapeutics.

Authors:  Namrata N Patil; Vijay Wadhwan; Minal Chaudhary; Abhishek Singh Nayyar
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec

6.  Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies.

Authors:  Jundong Zhu; Chenkui Miao; Shouyong Liu; Ye Tian; Chao Zhang; Chao Liang; Aiming Xu; Qiang Cao; Zengjun Wang
Journal:  Onco Targets Ther       Date:  2017-12-06       Impact factor: 4.147

7.  Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma.

Authors:  Zongzhu Zheng; Ruihua Tian; Ping Wang
Journal:  World J Surg Oncol       Date:  2017-11-29       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.